The prevalence of metabolic syndrome (MetS) is increasing, and obesity, insulin resistance, and inflammation are the known risk factors. However, results of previous studies regarding the relationship between MetS and inflammation have not been consistent. This study aimed to identify the associations between C-reactive protein (CRP) and MetS and its components in obese and non-obese men and women. Methods: This was a cross-sectional study based on the 6th Korea National Health and Nutrition Examination Survey (2015), and a nationally representative sample of 3,013 Korean adults aged 40-78 years were included. Those with cardiovascular disease, cancer, CRP level >10 mg/L, white blood cell count >10,000/mm 3 , chronic kidney disease, and lung/liver disease were excluded. Results: Approximately 11.0%, 50.0%, 8.4%, and 48.8% of non-obese men, obese men, non-obese women, and obese women presented with MetS (P<0.001), respectively. In all four groups, those who presented with MetS or its components showed a higher high-sensitivity (hs-CRP) average than those without. Multivariate regression analysis showed the increased risk of developing MetS with higher quartiles of hs-CRP level in obese (3rd and 4th quartiles: odds ratios [ORs], 3.87 and 2.57, respectively) and non-obese women (4th quartile: OR, 2.63). The different components also showed increased ORs in the four groups. However, no statistically significant trend in the relationship was found in men. Conclusion: Low-grade inflammation may increase the risk of MetS in Korean women independent of adiposity. However, due to the cross-sectional design of the present study, further studies must be conducted to identify the causal relationship between inflammation and metabolic disorders.
INTRODUCTION
Metabolic syndrome (MetS) is characterized by the presence of dyslipidemia, hyperglycemia, elevated blood pressure, and abdominal obesity. Due to sedentary lifestyle and obesity, MetS has become one of the most common health issues globally. 1) Approximately 20%-30% of adults in several countries have MetS. 2) Numerous studies have shown that patients with MetS are more likely to develop diabetes mellitus and cardiovascular disease and die prematurely. Thus, the high prevalence of MetS has become a serious concern.
3)
MetS is thought to be correlated to a chronic low-grade inflammatory response, which is characterized by overt cytokine production and inflammatory signaling pathways. 4) It is also believed to be associated with obesity, adipokines, and insulin resistance. [5] [6] [7] However, there has been a controversy regarding the cause and effect interrelationships and the extent of contribution of each factor, and to date, the exact pathway associated with the condition has yet to be explained.
To the best of our knowledge, a national study evaluating the difference in the risk of MetS in terms of elevated C-reactive protein (CRP) level between obese and non-obese participants has not been conducted, and only a few international studies that included western populations have been carried out. In addition, most of these studies are not stratified by gender. Results have been scattered and are controversial. Thus, in this study, we aimed to investigate (1) the relationship between high-sensitivity CRP (hs-CRP) and MetS and (2) whether the relationship is different between obese and non-obese men and women in a representative Korean population.
METHODS

Study Participants
The Korea National Health and Nutrition Examination Survey (KNHANES) is a nationwide health and nutrition survey conducted annually by the Korea Centers for Disease Control and Prevention (KCDC) to identify the general health behaviors and status of the South Korean population, the incidence of common chronic diseases, and comprehensive nutritional data. 8) Between 2013 and 2015, the 6th KNHANES annually surveyed 3,840 households in 192 regions, which were representative of the Korean population. Recruitment of the participants was conducted using a stratified, multistage cluster sampling method utilizing sampling units and households as 1st and 2nd sampling units. Sampling units were chosen based on residential condition and geographical area, and then, 20 households from the units were selected using a systematic sampling method. Representability was ensured by assigning weight values to each participant for an equal probability of sampling. 
Data Collection
1) Survey
All participants who participated were asked to sign an informed consent before data collection. Health surveys and physical examinations were conducted at mobile medical centers, and interviews were performed by trained interviewers. Based on the results, we categorized income as high, upper-medium, lower-medium, and low and education as below elementary school, middle school graduate, high school graduate, and above college graduate. We defined current drinkers as those who consumed alcohol more than once within the last month;
smokers as current smokers (excluding ex-smokers); and moderate or vigorous physical activity (as compared to inactivity) as those who engaged in more than 2.5 hours of middle-strength exercise or 1.25 hours of high-strength exercise, or in mixed exercise that is equivalent to the former (1-minute high-strength=2-minute middle-strength) in a week.
2) Anthropometric data
Physical examinations were performed by trained medical staff in accordance to standardized procedures. Weight and height were measured while the participants were wearing light clothing without shoes, and each were measured to the nearest 0.1 cm and 0.1 kg. Body mass index (BMI) was calculated according to the height and weight measurements: BMI=body weight (kg)/height (m 2 ). Waist circumference was measured to the nearest 0.1 cm at the midpoint between the midaxillary lower end of the last rib and the upper rim of the iliac crest after the participants exhaled.
Blood pressure was manually measured 3 times at 30-second intervals using a mercury sphygmomanometer (Baumanometer Desk Model 0320; WA Baum Co., Copiague, NY, USA) after resting for a minimum of 5 minutes in sitting position. The average value of the 2nd and 3rd measurements was recorded.
3) Laboratory measurements
Venous blood samples were collected after a minimum of 8-hour fasting and were processed, immediately refrigerated, and placed in a cold storage while being transported to the central laboratory within 24
hours. Serum high-density lipoprotein (HDL) cholesterol level was measured using the homogeneous enzymatic colorimetric method, and triglyceride (TG) and glucose levels were obtained using the enzymatic and hexokinase ultraviolet methods utilizing the Hitachi Auto- 
Insulin Resistance
Homeostatic model assessment of insulin resistance (HOMA-IR) was used for estimating insulin sensitivity and was calculated using the following formula: 12) HOMA-IR=fasting insulin (μIU/mL)×fasting glucose (mg/dL)/405. We defined insulin resistance as a HOMA-IR score ≥2.5.
12)
Statistical Analysis
Statistical analyses were performed using the IBM SPSS software ver. 
RESULTS
Characteristics of the Participants
The clinical characteristics of the four groups are shown in Table 1 .
Waist circumference, systolic and diastolic blood pressure, fasting glucose level, and TG level were higher in the obese groups than in the non-obese groups, and men had higher values than women. The HOMA-IR score and hs-CRP level were highest in obese women and lowest in non-obese women. Approximately 11.0%, 50.0%, 8.4%, and 48.8% of non-obese men, obese men, non-obese women, and obese women presented with MetS, respectively (P<0.001 for all aforementioned).
Distribution of High-Sensitivity C-Reactive Protein Level Based on the Presence and Absence of Each Component of MetS, MetS, and Insulin Resistance
The mean hs-CRP levels were higher in the presence of MetS or insulin resistance (HOMA-IR score ≥2.5) in all four groups. In both nonobese groups, hyperTG, low HDL-C level, and high fasting glucose level yielded higher hs-CRP level. Moreover, non-obese women showed a higher hs-CRP level and high blood pressure (P<0.001), while nonobese men did not. In both obese groups, abdominal obesity correlated to higher hs-CRP level. Obese women showed higher hs-CRP level and hyperTG (P<0.05), and obese men had a high blood pressure (P<0.001) ( Table 2 ).
Distribution of Homeostatic Model Assessment of Insulin Resistance Score according to the Quartiles of HighSensitivity C-Reactive Protein
The range and median of the HOMA-IR score are shown by the quartiles of hs-CRP in Figure 1 . In all four groups, the median value and up- 
Association between High-Sensitivity C-Reactive Protein Level as well as Metabolic Syndrome and Its Components
The ORs of MetS and its components according to the quartiles of hs-CRP level are shown in Table 3 TG, low HDL-C level, and high fasting glucose level were found. Meanwhile, in obese men, the risk for high blood pressure was noted. However, no significant relationship was observed between the risk for high blood pressure and MetS or stepwise gradient (P-trend not significant). Values are presented as hs-CRP quartile ranges (mg/dL) or odds ratio (95% confidence interval), unless otherwise stated. Adjusted for age, education, smoking, alcohol, body mass index, income, and physical activity. Abdominal obesity, waist circumference >90 cm (men)/85 cm (women); hypertriglyceridemia, TG level ≥150 mg/dL; low HDLcholesterol level, HDL-cholesterol level <40 mg/dL (men)/50 mg/dL (women); high fasting glucose, fasting glucose level ≥100 mg/dL or use of antidiabetic agents or insulin; high BP, blood pressure ≥130/85 mm Hg or use of antihypertensive medications; metabolic syndrome, meeting 3 or more of the 5 aforementioned criteria. CRP, C-reactive protein; hs-CRP, high-sensitivity CRP; HDL, high-density lipoprotein; BP, blood pressure. *P-value <0.05, † P-value <0.01, ‡ P-value <0.001; calculated using the logistic regression model for odds ratios.
DISCUSSION
In Korea, data from the KNHANES indicate that the prevalence of MetS increased from 24.9% in 1998 to 31.3% in 2007 among Korean adults, 13) and based on our study, it further increased to 34% However, the results are controversial. Meanwhile, national studies have not been conducted. In addition, among these studies, only few were stratified by gender; most were adjusted for gender, and only one was stratified by sex. This study was conducted to evaluate the relationship between MetS and hs-CRP level and to identify a difference in the association between these four groups: obese and non-obese men and women.
Our study showed that hs-CRP level plays a major role in the development of MetS independent of adiposity in women. A positive association was found between hyperTG and low HDL-C level in both obese and non-obese women across the quartiles of hs-CRP level, and no significant change was observed in terms of the risks after adjusting for BMI. However, in men, after adjusting for BMI, the strong positive associations between hs-CRP level and hyperTG, low HDL-C, high fasting glucose level, and MetS (data not shown) were attenuated and some were annulled. Although hyperTG and low HDL-C level mildly increased the risk in terms of the higher quartiles of the non-obese participants and high blood pressure in obese individuals, no statistically significant linear tendency was observed in our final model that included BMI. Our finding is in accordance with those of the study on
Mexicans by Han et al. 16) that was stratified by gender and adiposity.
Pradhan et al. 17) have also found that hs-CRP level is independently associated with hyperinsulinemia in both overweight and lean Caucasian women. However, men were not included in the study. 19) McLaughlin et al., 20) and Stenholm et al. 21) Other studies have shown varying amounts of association depending on obesity status, of which some are positive correlated to BMI and some are not. 7, 16, [22] [23] [24] [25] Previous studies on the relationship between inflammation and MetS/insulin resistance based on gender differences were also controversial, although most studies showed stronger associations in women than in men, which is similar our result. which is in contrast to our study result. However, the participants who took voluntary health examinations were from rural areas; thus, it was not a proper representative sample of Koreans.
There are several possible explanations behind our observation.
First, subclinical inflammation may have a greater role in inhibiting the actions of insulin in women due to differences in sex hormones.
For instance, inflammation may interact with female sex hormones and reduce the protective effects of estrogen on fat distribution and insulin action. Previous studies have shown that cytokines may interfere with estradiol secretion, 28) and oral estrogen may increase CRP levels. 29) Second, a higher number of female participants was analyzed, thus obtaining greater statistical power. Third, hs-CRP level could be merely a reflection of other more potent visceral adipokines, as similar as BMI in women have more fat mass and abdominal distribution, thus more interleukin-1, interleukin-6, and TNF-α are released, which do not only induce the hepatic synthesis of CRP but also various inflammatory effects. 30) In relation to this, visceral adipocytokines are more potent, and they cause chronic inflammation compared to other inflammatory mediators. Fourth, while we divided the quartiles of CRP separately for obese and non-obese participants, most studies used a common division of CRP, such as the study by Ye et al., 7) and this indicates that our model was more detailed and intricate. Finally, since there were no studies on the Korean population, it might be due https://doi.org/10.4082/kjfm.17.0075
to a racial/genetic difference in the predisposition to MetS.
Our study has several strengths. To the best of our knowledge, this is the first large-scale, population-based study that investigated CRP distribution and its relation with updated NCEP-ATP III criteria for MetS among obese and non-obese individuals in Korea, and this study is among the few studies that were additionally stratified by gender worldwide. In addition, most confounding factors for the risk of MetS in this study were cautiously taken into consideration. The present study used the most recent data. However, the present study also had some limitations. CRP levels differ in terms of anti-inflammatory drugs and diet, which could not be considered due to limitations in research data. Moreover, total body fat mass or body fat composition based on the total or visceral depots was not evaluated for the same reason;
Thus, a discrimination of lean but metabolically obese individuals and vice versa was not possible. Finally, the cross-sectional design does not allow for the discrimination of whether inflammation is a cause or a result of MetS and/or obesity and insulin resistance.
In conclusion, based on our study, low-grade inflammation important the pathogenesis of MetS in women, regardless of obesity status.
We can also argue that such association was not found in men, and rather, BMI may be the most significant risk factor. Thus, we may need to pay close attention to inflammatory markers in women, and actively controlling low-grade inflammation may be beneficial in the prevention and management of metabolic disorders. Specific actions for such condition may include the usage of statins and angiotensin-converting enzyme inhibitors, aspirin, and insulin-sensitizing agents, such as thiazolidinedione, and physical exercise. In addition, since we observed strong associations in both obese and non-obese women, CRP evaluation could identify a broader group of individuals who might be at high risk of metabolic disorders, irrespective of weight. Since hs-CRP level is the most standardized and commonly used inflammatory marker, it could be of clinical value in predicting and monitoring MetS in women. More detailed studies must be conducted before firm conclusions can be drawn, particularly regarding sex differences.
